Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Heald

Showing results (81-90 of 104) with videos related to

Pageof 11
Sort By:
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitorsAndrew D Morley, Peter W Kenny, Brenda Burton, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 1999
Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT(1A) and 5-HT re-uptake ligandsM B van Niel, M S Beer, J L Castro, et al.
Journal of Medicinal Chemistry|March 3, 1999
Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptorF Sternfeld, A R Guiblin, R A Jelley, et al.
Journal of Medicinal Chemistry|February 6, 2008
Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agentsMai-Kim Cheng, Chetna Modi, Jennifer C Cookson, et al.
Journal of Psychopharmacology (Oxford, England)|May 6, 2016
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatmentStephen J Cooper, Gavin P Reynolds, , et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral AnglesBrian S Safina, Richard L Elliott, Andrew K Forrest, et al.
Journal of Medicinal Chemistry|April 18, 2012
Discovery of novel allosteric mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors possessing bidentate Ser212 interactionsRobert A Heald, Philip Jackson, Pascal Savy, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitorsSteve Price, Walter Bordogna, Ruth Braganza, et al.
Journal of Medicinal Chemistry|November 27, 2025
Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of BronchiectasisElisabetta Armani, Andrea Rizzi, Daniela Miglietta, et al.
Journal of Medicinal Chemistry|June 23, 1999
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profilesM B van Niel, I Collins, M S Beer, et al.
Pageof 11

Showing results (81-90 of 104) with videos related to

Sort By:
Pageof 11
Bioorganic & Medicinal Chemistry Letters|February 24, 2009
5-Aminopyrimidin-2-ylnitriles as cathepsin K inhibitorsAndrew D Morley, Peter W Kenny, Brenda Burton, et al.
Bioorganic & Medicinal Chemistry Letters|November 27, 1999
Parallel synthesis of 3-aryloxy-2-propanolamines and evaluation as dual affinity 5-HT(1A) and 5-HT re-uptake ligandsM B van Niel, M S Beer, J L Castro, et al.
Journal of Medicinal Chemistry|March 3, 1999
Synthesis and serotonergic activity of 3-[2-(pyrrolidin-1-yl)ethyl]indoles: potent agonists for the h5-HT1D receptor with high selectivity over the h5-HT1B receptorF Sternfeld, A R Guiblin, R A Jelley, et al.
Journal of Medicinal Chemistry|February 6, 2008
Antitumor polycyclic acridines. 20. Search for DNA quadruplex binding selectivity in a series of 8,13-dimethylquino[4,3,2-kl]acridinium salts: telomere-targeted agentsMai-Kim Cheng, Chetna Modi, Jennifer C Cookson, et al.
Journal of Psychopharmacology (Oxford, England)|May 6, 2016
BAP guidelines on the management of weight gain, metabolic disturbances and cardiovascular risk associated with psychosis and antipsychotic drug treatmentStephen J Cooper, Gavin P Reynolds, , et al.
ACS Medicinal Chemistry Letters|September 27, 2017
Design of Selective Benzoxazepin PI3Kδ Inhibitors Through Control of Dihedral AnglesBrian S Safina, Richard L Elliott, Andrew K Forrest, et al.
Journal of Medicinal Chemistry|April 18, 2012
Discovery of novel allosteric mitogen-activated protein kinase kinase (MEK) 1,2 inhibitors possessing bidentate Ser212 interactionsRobert A Heald, Philip Jackson, Pascal Savy, et al.
Bioorganic & Medicinal Chemistry Letters|November 17, 2006
Identification and optimisation of a series of substituted 5-pyridin-2-yl-thiophene-2-hydroxamic acids as potent histone deacetylase (HDAC) inhibitorsSteve Price, Walter Bordogna, Ruth Braganza, et al.
Journal of Medicinal Chemistry|November 27, 2025
Design, Synthesis, and Biological Evaluation of the Novel Neutrophil Elastase Inhibitor CHF-6333 for the Inhaled Treatment of BronchiectasisElisabetta Armani, Andrea Rizzi, Daniela Miglietta, et al.
Journal of Medicinal Chemistry|June 23, 1999
Fluorination of 3-(3-(piperidin-1-yl)propyl)indoles and 3-(3-(piperazin-1-yl)propyl)indoles gives selective human 5-HT1D receptor ligands with improved pharmacokinetic profilesM B van Niel, I Collins, M S Beer, et al.
Pageof 11